ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,885
0,30%
Bitcoin
59 831,17
1,20%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSX
  6. Theratechnologies Inc (TH)

  7. Theratechnologies Inc (TH) Actualités

TH Theratechnologies Inc

1,77
-0,02 (-1,12%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Theratechnologies Inc TH Toronto Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,02 -1,12% 1,77 22:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,80 1,76 1,80 1,77 1,79
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202413:30GLOBETheratechnologies to Present Long-Term Efficacy, Safety and..
15/4/202422:15GLOBETheratechnologies Announces Mailing of Management Proxy..
11/4/202413:30GLOBETheratechnologies to Present at the 2024 Bloom Burton & Co...
10/4/202413:30GLOBETheratechnologies Reports Financial Results and Provides..
08/4/202422:30GLOBETheratechnologies Preclinical Data Presentation at AACR 2024..
05/4/202417:00GLOBETheratechnologies Appoints Elina Tea to its Board of..
03/4/202413:30GLOBETheratechnologies to Announce First Quarter 2024 Financial..
28/3/202412:30GLOBETheratechnologies to Present Preclinical Data at AACR on..
22/3/202414:36GLOBETheratechnologies Announces Update on its Preclinical..
22/3/202401:00GLOBETheratechnologies Appoints Jordan Zwick to its Board of..
21/3/202412:30GLOBETheratechnologies Initiates Increased Dose Level in Phase 1..
29/2/202422:34GLOBETheratechnologies Announces the Resignation of One of Its..
27/2/202413:30GLOBETheratechnologies Receives Refusal to File Letter for..
21/2/202413:30GLOBETheratechnologies Reports Financial Results for the Fourth..
20/2/202413:30GLOBETheratechnologies Announces Publication in Frontiers in..
15/2/202413:30GLOBETheratechnologies Completes Enrollment of First Six Patients..
06/2/202413:30GLOBETheratechnologies to Announce Fourth Quarter and Full Year..
24/1/202416:47DJNTheratechnologies Shares Sink at Open After FDA Rejects..
24/1/202414:52DJNTheratechnologies Shares Slide Premarket as FDA Turns Away..
24/1/202413:49DJNTheratechnologies: FDA Rejects Newer Egrifta Formulation
24/1/202413:00GLOBETheratechnologies Receives Complete Response Letter (CRL)..
23/1/202416:16DJNTheratechnologies Shares Fall as FDA Continues to Review..
23/1/202413:30GLOBETheratechnologies Receives Update from FDA on Tesamorelin F8..
02/1/202415:00APSWill This Dual-Listed Bio-Pharma Catch New Year Action?
02/1/202413:30GLOBETheratechnologies Submits sBLA for Trogarzo® Intramuscular..
21/12/202322:12PRNCATheratechnologies annonce le renouvellement de son..
21/12/202322:09PRNUSTheratechnologies Announces Renewal of Shelf Prospectus and..
13/12/202313:30GLOBETheratechnologies Announces FDA Approval of Trogarzo®..
24/11/202313:30GLOBETheratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation..
31/10/202317:34GLOBETheratechnologies Announces Closing of US$25 Million Public..
26/10/202314:00GLOBETheratechnologies Announces Pricing of US$25 Million Public..
25/10/202322:13GLOBETheratechnologies Announces Proposed Public Offering of..
24/10/202313:00GLOBETheratechnologies Announces Operational Update
19/10/202313:30GLOBETheratechnologies’ Ibalizumab Demonstrates..
16/10/202313:30GLOBETheratechnologies Announces Finalization of Amendments to..
13/10/202313:30GLOBETheratechnologies Presents Data at ID Week Showing..
13/10/202313:00GLOBETheratechnologies Announces Results from Trogarzo®..
12/10/202313:30GLOBETheratechnologies Announces Dosing of First Patient in..
04/10/202313:30GLOBETheratechnologies Receives January 2024 PDUFA Goal Date for..
26/9/202313:30GLOBETheratechnologies Reports Financial Results for the Third..
25/9/202313:30GLOBETheratechnologies Announces Agreement in Principle with..
25/9/202313:00GLOBETheratechnologies Submits Tesamorelin F8 Formulation sBLA..
20/9/202313:00GLOBETheratechnologies to Present at the Cantor Fitzgerald Global..
18/9/202322:15GLOBETheratechnologies to Announce Third Quarter 2023 Financial..
07/9/202319:57GLOBETheratechnologies to Present at the H.C. Wainwright 25th..
05/9/202313:00GLOBETheratechnologies Announces Certain Preliminary Q3 2023..
30/8/202316:34GLOBETheratechnologies Announces All U.S. Oncology Clinical Sites..
21/8/202321:24PRNUSToronto Stock Exchange, Theratechnologies Inc., View From..
31/7/202315:00APSBiopharma Firm Completes Reverse Stock Split
31/7/202313:00GLOBETheratechnologies Completes 1-for-4 Reverse Stock Split

Dernières Valeurs Consultées

TSX
TH
Theratechnologies
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés